BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31325663)

  • 1. Gender Disparity in Referral for Definitive Care of Malignant Pleural Effusions.
    Foote DC; Burke CR; Pandian B; Banks S; Haug KL; Hipp M; Zhao L; Smola B; Roh M; Carrott PW; Lynch WR; Chang AC; Lin J; Reddy RM
    J Surg Res; 2019 Dec; 244():409-416. PubMed ID: 31325663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality Gaps and Comparative Effectiveness of Management Strategies for Recurrent Malignant Pleural Effusions.
    Ost DE; Niu J; Zhao H; Grosu HB; Giordano SH
    Chest; 2018 Feb; 153(2):438-452. PubMed ID: 28864054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of clinical use of pleurodesis and/or indwelling pleural catheter therapy for malignant pleural effusion.
    Fysh ETH; Bielsa S; Budgeon CA; Read CA; Porcel JM; Maskell NA; Lee YCG
    Chest; 2015 Jun; 147(6):1629-1634. PubMed ID: 25474713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Better effect of intrapleural perfusion with hyperthermic chemotherapy by video-assisted thoracoscopic surgery for malignant pleural effusion treatment compared to normothermic chemoperfusion of the pleural cavity.
    Cao Y; Zhang Q; Huang Z; Chai Z; Liu J; Wang J; Sun Z; Zhao T; Wang G; Chen G; Han Y; Li Q; Hong X
    Cancer Med; 2022 Jan; 11(2):348-357. PubMed ID: 34854253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Talc pleurodesis as surgical palliation of patients with malignant pleural effusion. Analysis of factors affecting survival.
    Lumachi F; Mazza F; Ermani M; Chiara GB; Basso SM
    Anticancer Res; 2012 Nov; 32(11):5071-4. PubMed ID: 23155281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Systemic Anticancer Therapy Associated With Higher Rates of Malignant Pleural Effusion Control in People With Pharmacologically Sensitive Tumors?: A Retrospective Analysis of Prospectively Collected Data.
    Holling N; Patole S; Medford ARL; Maskell NA; Bibby AC
    Chest; 2021 Nov; 160(5):1915-1924. PubMed ID: 34023321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of thoracic ultrasonography in pleurodesis pathways for malignant pleural effusions (SIMPLE): an open-label, randomised controlled trial.
    Psallidas I; Hassan M; Yousuf A; Duncan T; Khan SL; Blyth KG; Evison M; Corcoran JP; Barnes S; Reddy R; Bonta PI; Bhatnagar R; Kagithala G; Dobson M; Knight R; Dutton SJ; Luengo-Fernandez R; Hedley E; Piotrowska H; Brown L; Asa'ari KAM; Mercer RM; Asciak R; Bedawi EO; Hallifax RJ; Slade M; Benamore R; Edey A; Miller RF; Maskell NA; Rahman NM
    Lancet Respir Med; 2022 Feb; 10(2):139-148. PubMed ID: 34634246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions for the management of malignant pleural effusions: a network meta-analysis.
    Clive AO; Jones HE; Bhatnagar R; Preston NJ; Maskell N
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD010529. PubMed ID: 27155783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Talc pleurodesis improves survival of patients with malignant pleural effusions: case-control study.
    Korsic M; Badovinac S; Cucevic B; Janevski Z
    Wien Klin Wochenschr; 2015 Dec; 127(23-24):963-9. PubMed ID: 25860847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procedures Performed during Hospitalizations for Malignant Pleural Effusions: Data from the 2012 National Inpatient Sample.
    Fortin M; Taghizadeh N; Tremblay A
    Respiration; 2018; 95(4):228-234. PubMed ID: 29414821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors affecting survival in non-small cell lung carcinoma patients with malignant pleural effusions.
    Kasapoglu US; Arınç S; Gungor S; Irmak I; Guney P; Aksoy F; Bandak D; Hazar A
    Clin Respir J; 2016 Nov; 10(6):791-799. PubMed ID: 25764010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and management of malignant pleural effusions.
    Heffner JE
    Respirology; 2008 Jan; 13(1):5-20. PubMed ID: 18197908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Quality of Life after Pleurodesis in Patients with Malignant Pleural Effusion.
    Terra RM; Costa PB; Dela Vega AJM; Araujo PHXN; Teixeira LR; Pêgo-Fernandes PM
    Respiration; 2019; 98(6):467-472. PubMed ID: 31694026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients.
    Hirata T; Yonemori K; Hirakawa A; Shimizu C; Tamura K; Ando M; Katsumata N; Tanimoto M; Fujiwara Y
    Eur Respir J; 2011 Dec; 38(6):1425-30. PubMed ID: 21565923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indwelling Pleural Catheter versus Pleurodesis for Malignant Pleural Effusions. A Systematic Review and Meta-Analysis.
    Iyer NP; Reddy CB; Wahidi MM; Lewis SZ; Diekemper RL; Feller-Kopman D; Gould MK; Balekian AA
    Ann Am Thorac Soc; 2019 Jan; 16(1):124-131. PubMed ID: 30272486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of thoracoscopic mechanical pleurodesis for the treatment of malignant pleural effusions.
    Crnjac A
    Wien Klin Wochenschr; 2004; 116 Suppl 2():28-32. PubMed ID: 15506307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventional therapies for malignant pleural effusions: the present and the future.
    Thomas R; Francis R; Davies HE; Lee YC
    Respirology; 2014 Aug; 19(6):809-22. PubMed ID: 24947955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indwelling pleural catheters for malignancy-associated pleural effusion: report on a single centre's ten years of experience.
    Frost N; Brünger M; Ruwwe-Glösenkamp C; Raspe M; Tessmer A; Temmesfeld-Wollbrück B; Schürmann D; Suttorp N; Witzenrath M
    BMC Pulm Med; 2019 Dec; 19(1):232. PubMed ID: 31791305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival Difference in Patients with Malignant Pleural Effusions Treated with Pleural Catheter or Talc Pleurodesis.
    Liou DZ; Serna-Gallegos D; Chan JL; Borgella J; Akhmerov S; Soukiasian HJ
    Am Surg; 2016 Oct; 82(10):995-999. PubMed ID: 27779992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B.
    Noro R; Kobayashi K; Usuki J; Yomota M; Nishitsuji M; Shimokawa T; Ando M; Hino M; Hagiwara K; Miyanaga A; Seike M; Kubota K; Gemma A;
    Thorac Cancer; 2020 Jul; 11(7):1876-1884. PubMed ID: 32421226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.